Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Lotte M. de Boer, Albert Wiegman, Daniel I. Swerdlow, John J.P. Kastelein & Barbara A. Hutten. (2022) Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions. Expert Opinion on Pharmacotherapy 23:14, pages 1601-1615.
Read now
Read now
Ali A. Rizvi, Djordje S. Popovic, Nikolaos Papanas, Anca Pantea Stoian, Wael Al mahmeed, Amirhossein Sahebkar, Andrej Janez & Manfredi Rizzo. (2022) Current and emerging drugs for the treatment of atherosclerosis: the evidence to date. Expert Review of Cardiovascular Therapy 20:7, pages 515-527.
Read now
Read now
Ivan Pećin & Željko Reiner. (2021) Novel Experimental Agents for the Treatment of Hypercholesterolemia. Journal of Experimental Pharmacology 13, pages 91-100.
Read now
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang & Christopher Wai Kei Lam. (2020) Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert Opinion on Pharmacotherapy 21:17, pages 2137-2151.
Read now
Read now
Chang Hoon Lee, Francesco Franchi & Dominick J. Angiolillo. (2020) Clopidogrel drug interactions: a review of the evidence and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1079-1096.
Read now
Read now
Maria del Mar Gutierrez, Mª Gracia Mateo, Noemí Corbacho, Francesc Vidal & Pere Domingo. (2019) Drug-drug interactions when treating HIV-related metabolic disorders. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 787-802.
Read now
Read now
Cezary Wójcik. (2017) Incorporation of PCSK9 inhibitors into prevention of atherosclerotic cardiovascular disease. Postgraduate Medicine 129:8, pages 801-810.
Read now
Read now
Maria-Corina Serban, Maciej Banach & Dimitri P Mikhailidis. (2016) Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options. Expert Opinion on Pharmacotherapy 17:3, pages 369-380.
Read now
Read now
Amedeo Lonardo, Stefano Ballestri, Giovanni Targher & Paola Loria. (2015) Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 9:5, pages 629-650.
Read now
Read now
Linda Dayer-Berenson, Mary Finckenor & Michelle Tuzzolino. (2014) Are add-on agents to statin therapy necessary in hypercholesterolemia?. Clinical Lipidology 9:6, pages 695-707.
Read now
Read now
JoAnne M Foody, Peter P Toth, Andrew M Tershakovec, Thomas Musliner, Joanne E Tomassini, Robert S Lowe, David R Neff & Harry R Davis. (2014) Efficacy and safety of ezetimibe plus atorvastatin therapy. Clinical Lipidology 9:4, pages 441-470.
Read now
Read now
Kazuhiko Kotani. (2013) An update on serum amyloid A–LDL and its potential use for dyslipidemic patients receiving lipid-modulating treatment. Clinical Lipidology 8:4, pages 419-423.
Read now
Read now
Dirk J Blom, Adrian David Marais, Frederick J Raal & Gilles Lambert. (2013) The potential use of monoclonal antibodies and other novel agents as drugs to lower LDL cholesterol. Clinical Lipidology 8:2, pages 243-256.
Read now
Read now
Articles from other publishers (38)
Adrianna Dec, Aleksandra Niemiec, Eliza Wojciechowska, Mateusz Maligłówka, Łukasz Bułdak, Aleksandra Bołdys & Bogusław Okopień. (2023) Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy. International Journal of Molecular Sciences 24:7, pages 6858.
Crossref
Crossref
ARUN NANDA & RACHNA ANAND. (2022) FORMULATION AND EVALUATION OF COCRYSTALS OF A BCS CLASS II DRUG USING GLYCINE AS COFORMER. International Journal of Applied Pharmaceutics, pages 68-76.
Crossref
Crossref
Dhruva Chauhan, Farzana Memon, Vaibhav Patwardhan, Priya Kotwani, Parth Shah & Vikramaditya Samala Venkata. (2022) Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review. Cureus.
Crossref
Crossref
Fistra Janrio Tandirerung. (2022) The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia. Current Cardiology Reports 24:11, pages 1669-1677.
Crossref
Crossref
Jelani K. Grant, Sarah Snow, Michelle Kelsey, Jennifer Rymer, Anna E. Schaffer, Manesh R. Patel, Robert W. McGarrah, Neha J. Pagidipati & Nishant P. Shah. (2022) Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach. Current Cardiology Reports 24:10, pages 1373-1385.
Crossref
Crossref
Silvina Ilut, Bianca O. Pirlog, Radu Pirlog, Andreea Nutu, Vitalie Vacaras & Sebastian M. Armean. (2022) Recent Advances on the Roles of PCSK-9 Inhibitors in the Management of Acute Ischemic Stroke Patients. International Journal of Molecular Sciences 23:18, pages 10221.
Crossref
Crossref
Ezgi Dayar & Olga Pechanova. (2022) Targeted Strategy in Lipid-Lowering Therapy. Biomedicines 10:5, pages 1090.
Crossref
Crossref
Satpute Vivek Mahavir & Punit R. Rachh. (2022) Formulation and evaluation of selexipag and ezetimibe bi-layer tablet by novel approach. International journal of health sciences, pages 3256-3275.
Crossref
Crossref
Shun Li & C. M. Schooling. (2022) Investigating the effects of statins on ischemic heart disease allowing for effects on body mass index: a Mendelian randomization study. Scientific Reports 12:1.
Crossref
Crossref
Panagiotis Anagnostis, Matilda Florentin, Sarantis Livadas, Irene Lambrinoudaki & Dimitrios G. Goulis. (2022) Bone Health in Patients with Dyslipidemias: An Underestimated Aspect. International Journal of Molecular Sciences 23:3, pages 1639.
Crossref
Crossref
Stefan Simić, Erna Zukić, Luca Schmermund, Kurt Faber, Christoph K. Winkler & Wolfgang Kroutil. (2021) Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods. Chemical Reviews 122:1, pages 1052-1126.
Crossref
Crossref
Chang Su, Yongzheng Lu, Zeyu Wang, Jiacheng Guo, Yachen Hou, Xiaofang Wang, Zhen Qin, Jiamin Gao, Zhaowei Sun, Yichen Dai, Yu Liu, Guozhen Liu, Xunde Xian, Xiaolin Cui, Jinying Zhang & Junnan Tang. (2022) Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics. Aging and disease, pages 0.
Crossref
Crossref
Marta Biernacka, Tatsiana Ilyich, Ilya Zavodnik, Bartłomiej Pałecz & Artur Stepniak. (2021) Studies of the Formation and Stability of Ezetimibe-Cyclodextrin Inclusion Complexes. International Journal of Molecular Sciences 23:1, pages 455.
Crossref
Crossref
Yoshiki HOSHINO, Takaaki SUGIHARA, Suguru IKEDA, Ryohei TARUMOTO, Yukako MATSUKI, Tsutomu KANDA, Takuji IYAMA, Tomoaki TAKATA, Tomomitsu MATONO, Takakazu NAGAHARA, Jun-ichi OKANO, Masaru UEKI, Masahiko KODA, Mitsuhiko OSAKI, Futoshi OKADA & Hajime ISOMOTO. (2021) Newly Invented Micellized Vitamin K2 Recovered Prolonged Prothrombin Time under Obstructive Jaundice in Rats with Bile Duct Ligation. Journal of Nutritional Science and Vitaminology 67:6, pages 397-403.
Crossref
Crossref
Uma Sai Teja Yarra & Sowjanya Gummadi. (2021) Stability indicating RP-UPLC method for simultaneous quantification of bempedoic acid and ezetimibe in bulk and pharmaceutical formulations. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
Shun Li & C. M. Schooling. (2021) A phenome-wide association study of genetically mimicked statins. BMC Medicine 19:1.
Crossref
Crossref
Umidakhon Makhmudova, P. Christian Schulze, Anja Vogt & Oliver Weingärtner. (2021) Kardiovaskuläre Hochrisikopatienten: Hilfe bei der LDL-C-Zielwerterreichung. CardioVasc 21:6, pages 35-38.
Crossref
Crossref
Isabella Bonilha, Eric Hajduch, Beatriz Luchiari, Wilson Nadruz, Wilfried Le Goff & Andrei C. Sposito. (2021) The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus. Metabolites 11:12, pages 807.
Crossref
Crossref
Isabella Giacomini, Federico Gianfanti, Maria Andrea Desbats, Genny Orso, Massimiliano Berretta, Tommaso Prayer-Galetti, Eugenio Ragazzi & Veronica Cocetta. (2021) Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. Frontiers in Oncology 11.
Crossref
Crossref
Mateo M. Salgado, Alejandro Manchado, Carlos T. Nieto, David Díez & Narciso M. Garrido. (2021) Synthesis and Modeling of Ezetimibe Analogues. Molecules 26:11, pages 3107.
Crossref
Crossref
Ioannis D. Karantas, Mehmet E. Okur, Neslihan Ü. Okur & Panoraia I. Siafaka. (2021) Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:5, pages 815-834.
Crossref
Crossref
Qian Xu, Yiming Deng, Jun Xiao, Xiangrui Liu, Min Zhou, Zhong Ren, Juan Peng, Yaling Tang, Zhisheng Jiang, Zhihan Tang & Lushan Liu. (2021) Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab. Current Medicinal Chemistry 28:5, pages 1025-1041.
Crossref
Crossref
I. A. Alekseeva & M. V. Ezhov. (2020) Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy. Meditsinskiy sovet = Medical Council:14, pages 26-32.
Crossref
Crossref
Noriko Kameyama, Chizuko Maruyama, Yuri Shijo, Ariko Umezawa, Aisa Sato, Makoto Ayaori, Katsunori Ikewaki, Masako Waki & Tamio Teramoto. (2020) Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study. Journal of Atherosclerosis and Thrombosis 27:7, pages 683-694.
Crossref
Crossref
Satoshi Yamaguchi, Kageyuki Oba, Moritake Higa, Osamu Arasaki & Michio Shimabukuro. (2020) Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus. Journal of Clinical Medicine 9:6, pages 1675.
Crossref
Crossref
Dirk Müller-Wieland, Michael Lehrke, Corinna Lebherz, Katharina Schütt & Nikolaus Marx. (2020) Dyslipidämien: Aktuelles Lipid-Management. Deutsches Ärzteblatt Online.
Crossref
Crossref
Juan Camilo Losada Díaz, Jacobo Cepeda del Castillo, Edwin Alexander Rodriguez-López & Carlos J. Alméciga-Díaz. (2019) Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses. International Journal of Molecular Sciences 21:1, pages 232.
Crossref
Crossref
Carlos J. Alméciga-Diaz, Oscar A. Hidalgo, Sergio Olarte-Avellaneda, Alexander Rodríguez-López, Esteban Guzman, Rafael Garzón, Luisa Natalia Pimentel-Vera, María Alejandra Puentes-Tellez, Andrés Felipe Rojas-Rodriguez, Kirill Gorshkov, Rong Li & Wei Zheng. (2019) Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA. Journal of Medicinal Chemistry 62:13, pages 6175-6189.
Crossref
Crossref
David Karásek. (2019) Ezetimibe in the treatment of hypercholesterolaemia. Interní medicína pro praxi 21:2, pages 112-116.
Crossref
Crossref
Milan Kvapil. (2019) Strategy and tactics of treatment of type 2 diabetes mellitus. Vnitřní lékařství 65:4, pages 273-278.
Crossref
Crossref
Guilherme A. G. Martins, Fabio S. Murakami, Maximiliano S. Sangoi, Vitor Todeschini, Larissa S. Bernardi & Paulo R. Oliveira. (2019) Characterization, Purity Determination and Decomposition Kinetics of Ezetimibe Under Non-Isothermal Conditions. Current Pharmaceutical Analysis 15:4, pages 327-332.
Crossref
Crossref
Jong-Gil Park & Goo Taeg Oh. (2019) Current pharmacotherapies for atherosclerotic cardiovascular diseases. Archives of Pharmacal Research 42:3, pages 206-223.
Crossref
Crossref
Yutong Fei, Gordon Henry Guyatt, Paul Elias Alexander, Regina El Dib, Reed A.C. Siemieniuk, Per Olav Vandvik, Mark E. Nunnally, Huda Gomaa, Rebecca L. Morgan, Arnav Agarwal, Ying Zhang, Neera Bhatnagar & Frederick A. Spencer. (2017) Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient‐important outcomes. Journal of Evaluation in Clinical Practice 24:1, pages 222-231.
Crossref
Crossref
John E. Casida. (2017) Why Prodrugs and Propesticides Succeed. Chemical Research in Toxicology 30:5, pages 1117-1126.
Crossref
Crossref
Atsushi Shinnakasu, Kiyoaki Yamamoto, Mihoko Kurano, Hiroshi Arimura, Aiko Arimura, Akira Kikuti, Hiroshi Hashiguchi, Takahisa Deguchi & Yoshihiko Nishio. (2017) The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis 24:7, pages 735-748.
Crossref
Crossref
Azin Jahangiri, Khosro Adibkia, Karim Asadpour-Zeynali, Yousef Javadzadeh, Hamed Hamishehkar & Mohammad Barzegar-Jalali. (2016) Application of Multivariate Calibration Methods, in Dissolution Testing and Simultaneous Determination of Atorvastatin and Ezetimibe in Their Combined Solid Dosage Form. Pharmaceutical Sciences 22:2, pages 105-111.
Crossref
Crossref
Katriina Nemes, Fredrik Åberg, Helena Gylling & Helena Isoniemi. (2016) Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications. World Journal of Hepatology 8:22, pages 924.
Crossref
Crossref
Florian A. Lempp & Stephan Urban. (2014) Inhibitors of Hepatitis B Virus Attachment and Entry. Intervirology 57:3-4, pages 151-157.
Crossref
Crossref